Purinergic P1 Receptor Antagonists
"Purinergic P1 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.
| Descriptor ID |
D058915
|
| MeSH Number(s) |
D27.505.519.625.725.400.100 D27.505.696.577.725.400.100
|
| Concept/Terms |
Purinergic P1 Receptor Antagonists- Purinergic P1 Receptor Antagonists
- P1 Purinoceptor Antagonists
- Antagonists, P1 Purinoceptor
- Purinoceptor Antagonists, P1
- Adenosine Receptor Antagonists
- Antagonists, Adenosine Receptor
- Receptor Antagonists, Adenosine
|
Below are MeSH descriptors whose meaning is more general than "Purinergic P1 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Purinergic P1 Receptor Antagonists".
This graph shows the total number of publications written about "Purinergic P1 Receptor Antagonists" by people in this website by year, and whether "Purinergic P1 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Purinergic P1 Receptor Antagonists" by people in Profiles.
-
Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial. Am J Ther. 2013 Nov-Dec; 20(6):622-9.
-
Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial. Int J Cardiovasc Imaging. 2013 Jun; 29(5):1029-37.